ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 258 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $24,805,000 | +60.3% | 266,885 | +2.7% | 0.01% | +40.0% |
| Q3 2021 | $15,473,000 | +16.3% | 259,789 | +33.1% | 0.01% | +25.0% |
| Q2 2021 | $13,310,000 | +17.1% | 195,153 | +19.2% | 0.00% | 0.0% |
| Q1 2021 | $11,363,000 | -16.7% | 163,762 | -7.7% | 0.00% | -20.0% |
| Q4 2020 | $13,639,000 | -5.7% | 177,500 | -8.2% | 0.01% | -16.7% |
| Q3 2020 | $14,460,000 | +58.7% | 193,333 | +33.6% | 0.01% | +50.0% |
| Q2 2020 | $9,111,000 | +228.3% | 144,739 | +119.0% | 0.00% | +300.0% |
| Q1 2020 | $2,775,000 | +121.3% | 66,080 | +139.8% | 0.00% | 0.0% |
| Q4 2019 | $1,254,000 | +48.4% | 27,557 | +49.3% | 0.00% | – |
| Q3 2019 | $845,000 | -62.6% | 18,461 | -52.1% | 0.00% | -100.0% |
| Q2 2019 | $2,259,000 | +117.0% | 38,525 | +65.8% | 0.00% | – |
| Q1 2019 | $1,041,000 | -28.0% | 23,236 | -29.9% | 0.00% | -100.0% |
| Q2 2018 | $1,445,000 | – | 33,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
| Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
| Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
| Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
| GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
| Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
| First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
| DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
| SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
| Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |